Amoy Diagnostics Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan Amoy Diagnostics will develop its PCR-based panel as a companion diagnostic in Japan to screen NSCLC patients for Amgen's KRAS G12C inhibitor. Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations. AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies. AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib. Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China AmoyDx will develop and seek regulatory approval in China for a lung cancer PCR panel to be used with Merck's MET inhibitor tepotinib. Aug 27, 2020 Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop CDx for Lung Cancer Treatment Aug 20, 2020 AmoyDx Strikes CDx Development Deal for Merck KGaA Cancer Drug Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Jan 3, 2020 Massachusetts Startup Focuses on Long-Read Sequencing Technology Premium Nov 25, 2019 AmoyDx, Eisai Form CDx Development Alliance Oct 4, 2019 In Brief This Week: Thermo Fisher, HalioDx, OncoCyte, Amoy Diagnostics, More Jun 24, 2019 AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy Mar 1, 2019 AmoyDx Wins Chinese Regulatory Approval for BRCA Mutation Test Jan 29, 2019 AmoyDx, Sanomics Ink Deal for Multigene Mutation Detection Kit Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Jan 29, 2018 AmoyDx, Medikonia Ink MDx Distribution Deal Jan 22, 2018 AmoyDx Wins Chinese Approval for Lung Cancer Liquid Biopsy CDx May 16, 2017 Amoy Dx Partners With Canbridge on CDx Development Feb 3, 2017 Japan Regulators Approve AmoyDx's Lung Cancer CDx Jul 28, 2016 Merck KGaA, AmoyDx Partner on Colorectal Cancer Test for Chinese Market Oct 1, 2015 AmoyDx, Illumina Partner to Develop NGS Cancer Diagnostics for Chinese Clinical Oncology Market Oct 24, 2014 Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays Oct 17, 2014 MoBiTec to Distribute Amoy's MDx Products in Germany Sep 3, 2014 Chinese Regulators Approve AmoyDx's ALK, ROS1 Gene Fusion Detection Kits Aug 29, 2013 OxOnc to Use Amoy Gene Fusion Kits in Trial of Pfizer Drug Load More Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.